Status:
COMPLETED
A Randomized Control Trial to Assess Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Implant Designs
Lead Sponsor:
Zimmer Biomet
Collaborating Sponsors:
Biomet U.K. Ltd.
Conditions:
Osteoarthritis
Eligibility:
All Genders
Up to 80 years
Phase:
NA
Brief Summary
This is a prospective Randomised Control Trial to compare the Early Clinical and Functional Outcome of the ROCC and LCS total knee arthroplasty implant designs.
Detailed Description
This study compares two similar designs of cementless rotating bearing total condylar knee replacements. The study will be conducted at a single clinical unit with a senior orthopaedic surgeon implant...
Eligibility Criteria
Inclusion
- Patients suitable for cementless knee replacement
- Patients skeletally mature and under 80 years of age at pre-operative clinic
- Patients presenting with osteoarthritis of the knee
- Patients must be ambulatory at time of pre-operative clinic
- Patients must be able to understand instructions and be will to return for follow-up
Exclusion
- Previous knee surgery (except arthroscopic/open menisectomy)
- Patients with inflammatory arthritis
- Patients with significant medical co-morbidity - ASA IV
- Disorders causing abnormal gait or significant pain
- Patients unable to consent
- Severe visual impairment
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00755144
Start Date
April 1 2007
End Date
January 1 2011
Last Update
June 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Musgrave Park Hospital
Belfast, United Kingdom